{"id":"https://openalex.org/W2895814896","doi":"https://doi.org/10.1016/j.ymthe.2018.10.002","title":"Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus","display_name":"Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus","publication_year":2018,"publication_date":"2018-10-11","ids":{"openalex":"https://openalex.org/W2895814896","doi":"https://doi.org/10.1016/j.ymthe.2018.10.002","mag":"2895814896","pmid":"https://pubmed.ncbi.nlm.nih.gov/30389355","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6318701"},"language":"en","primary_location":{"id":"doi:10.1016/j.ymthe.2018.10.002","doi":"https://doi.org/10.1016/j.ymthe.2018.10.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2018.10.002","pdf_url":"http://www.cell.com/article/S152500161830491X/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S152500161830491X/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040308280","display_name":"Lee Ann Campbell","orcid":"https://orcid.org/0000-0003-4724-1824","observed_orcids":["https://orcid.org/0000-0003-4724-1824"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lee A. Campbell","raw_affiliation_strings":["Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA. Electronic address: lee.campbell@nih.gov","Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA. Electronic address: lee.campbell@nih.gov","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"raw_affiliation_string":"Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068092697","display_name":"Lamarque M. Coke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lamarque M. Coke","raw_affiliation_strings":["Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086681709","display_name":"Christopher T. Richie","orcid":"https://orcid.org/0000-0002-7944-4928","observed_orcids":["https://orcid.org/0000-0002-7944-4928"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher T. Richie","raw_affiliation_strings":["Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051586809","display_name":"Lowella V. Fortuno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lowella V. Fortuno","raw_affiliation_strings":["Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070504924","display_name":"Aaron Y. Park","orcid":"https://orcid.org/0000-0001-5213-6960","observed_orcids":["https://orcid.org/0000-0001-5213-6960"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Y. Park","raw_affiliation_strings":["Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108880617","display_name":"Brandon K. Harvey","orcid":"https://orcid.org/0000-0002-4036-1383","observed_orcids":["https://orcid.org/0000-0002-4036-1383","https://orcid.org/0000-0002-7471-9937"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brandon K. Harvey","raw_affiliation_strings":["Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA. Electronic address: bharvey@mail.nih.gov","Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA. Electronic address: bharvey@mail.nih.gov","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"raw_affiliation_string":"Intramural Research Program, National Institute on Drug Abuse, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5040308280","https://openalex.org/A5108880617"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":3.1113,"has_fulltext":false,"cited_by_count":133,"citation_normalized_percentile":{"value":0.933506,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"27","issue":"1","first_page":"151","last_page":"163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.8125,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.8125,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.10369999706745148,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.03310000151395798,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-long-terminal-repeat","display_name":"HIV long terminal repeat","score":0.9350000023841858},{"id":"https://openalex.org/keywords/extracellular-vesicles","display_name":"extracellular vesicles","score":0.8330000042915344},{"id":"https://openalex.org/keywords/vsv-g","display_name":"vesicular stomatitis virus glycoprotein","score":0.9620000123977661},{"id":"https://openalex.org/keywords/hiv-latency","display_name":"HIV latency","score":0.4300000071525574},{"id":"https://openalex.org/keywords/microglia","display_name":"microglia","score":0.7689999938011169},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.7820000052452087},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9649999737739563},{"id":"https://openalex.org/keywords/hiv-cure","display_name":"HIV cure","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.8001124858856201},{"id":"https://openalex.org/C132455925","wikidata":"https://www.wikidata.org/wiki/Q16965677","display_name":"Cas9","level":4,"score":0.7028025984764099},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6969621181488037},{"id":"https://openalex.org/C75934600","wikidata":"https://www.wikidata.org/wiki/Q419245","display_name":"Ribonucleoprotein","level":4,"score":0.5863974690437317},{"id":"https://openalex.org/C102906071","wikidata":"https://www.wikidata.org/wiki/Q422467","display_name":"Provirus","level":4,"score":0.5511946082115173},{"id":"https://openalex.org/C2910020833","wikidata":"https://www.wikidata.org/wiki/Q1869477","display_name":"HIV Long Terminal Repeat","level":5,"score":0.5365251302719116},{"id":"https://openalex.org/C84356384","wikidata":"https://www.wikidata.org/wiki/Q7833575","display_name":"Trans-activating crRNA","level":5,"score":0.46847453713417053},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4505040943622589},{"id":"https://openalex.org/C2908689518","wikidata":"https://www.wikidata.org/wiki/Q21097485","display_name":"Extracellular vesicle","level":5,"score":0.42968130111694336},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3828279972076416},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3270165026187897},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.3123210668563843},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2544214129447937},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2272651195526123},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.2059052288532257},{"id":"https://openalex.org/C199491388","wikidata":"https://www.wikidata.org/wiki/Q1869477","display_name":"Long terminal repeat","level":4,"score":0.190797358751297},{"id":"https://openalex.org/C20518536","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicles","level":4,"score":0.14831137657165527},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.07444334030151367},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000072669","descriptor_name":"Gene Editing","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000076987","descriptor_name":"CRISPR-Associated Protein 9","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000076987","descriptor_name":"CRISPR-Associated Protein 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011533","descriptor_name":"Proviruses","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011533","descriptor_name":"Proviruses","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016325","descriptor_name":"HIV Long Terminal Repeat","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016325","descriptor_name":"HIV Long Terminal Repeat","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018116","descriptor_name":"Vesiculovirus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018116","descriptor_name":"Vesiculovirus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D034441","descriptor_name":"Heterogeneous-Nuclear Ribonucleoproteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D034441","descriptor_name":"Heterogeneous-Nuclear Ribonucleoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064113","descriptor_name":"CRISPR-Cas Systems","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D064113","descriptor_name":"CRISPR-Cas Systems","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D064113","descriptor_name":"CRISPR-Cas Systems","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ymthe.2018.10.002","doi":"https://doi.org/10.1016/j.ymthe.2018.10.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2018.10.002","pdf_url":"http://www.cell.com/article/S152500161830491X/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6318701","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6318701","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther","raw_type":"Text"},{"id":"pmid:30389355","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30389355","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy : the journal of the American Society of Gene Therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ymthe.2018.10.002","doi":"https://doi.org/10.1016/j.ymthe.2018.10.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2018.10.002","pdf_url":"http://www.cell.com/article/S152500161830491X/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F8394932145","display_name":"Intramural Research Program","ror":null}],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2895814896.pdf"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W137643597","https://openalex.org/W1555041989","https://openalex.org/W1874379912","https://openalex.org/W1966452674","https://openalex.org/W1974124274","https://openalex.org/W1978917197","https://openalex.org/W1986316308","https://openalex.org/W1990950572","https://openalex.org/W2027195751","https://openalex.org/W2030701238","https://openalex.org/W2036176224","https://openalex.org/W2066234893","https://openalex.org/W2073212790","https://openalex.org/W2076586496","https://openalex.org/W2077659966","https://openalex.org/W2080418767","https://openalex.org/W2080662545","https://openalex.org/W2084979113","https://openalex.org/W2088431157","https://openalex.org/W2093456378","https://openalex.org/W2099960858","https://openalex.org/W2105464583","https://openalex.org/W2106070783","https://openalex.org/W2116534141","https://openalex.org/W2119680107","https://openalex.org/W2121725913","https://openalex.org/W2128891846","https://openalex.org/W2143094150","https://openalex.org/W2155233217","https://openalex.org/W2163248265","https://openalex.org/W2288512038","https://openalex.org/W2289938426","https://openalex.org/W2292390328","https://openalex.org/W2296951880","https://openalex.org/W2319061195","https://openalex.org/W2326555481","https://openalex.org/W2357241585","https://openalex.org/W2469238969","https://openalex.org/W2522607873","https://openalex.org/W2534118568","https://openalex.org/W2542848066","https://openalex.org/W2552908886","https://openalex.org/W2560726086","https://openalex.org/W2588309240","https://openalex.org/W2594540404","https://openalex.org/W2666389453","https://openalex.org/W2747513888","https://openalex.org/W2754835295","https://openalex.org/W2767063890","https://openalex.org/W2767607752","https://openalex.org/W2767755769","https://openalex.org/W2775147596","https://openalex.org/W2782295218","https://openalex.org/W2782372577","https://openalex.org/W2782421321","https://openalex.org/W2791177166","https://openalex.org/W2793196316","https://openalex.org/W2793661486","https://openalex.org/W2794159346","https://openalex.org/W2806710969","https://openalex.org/W4200314887","https://openalex.org/W4230953083"],"related_works":["https://openalex.org/W4245958403","https://openalex.org/W2567006200","https://openalex.org/W2874925241","https://openalex.org/W2803197065","https://openalex.org/W4391485098","https://openalex.org/W2736295074","https://openalex.org/W4387582439","https://openalex.org/W7162014712","https://openalex.org/W3038867332","https://openalex.org/W2980933227"],"abstract_inverted_index":{"Investigators":[0],"have":[1],"utilized":[2,26],"the":[3,45,69,138,148],"CRISPR/Cas9":[4,195],"gene-editing":[5],"system":[6],"to":[7,15,34,101,141,193],"specifically":[8],"target":[9],"well-conserved":[10],"regions":[11],"of":[12,56,78,92,99,110,130],"HIV,":[13],"leading":[14],"decreased":[16],"infectivity":[17],"and":[18,22,61,74,85,151,169],"pathogenesis":[19],"in":[20,40,105,162],"vitro":[21],"ex":[23],"vivo.":[24],"We":[25],"a":[27,32,41,189],"specialized":[28],"extracellular":[29],"vesicle":[30],"termed":[31],"\"gesicle\"":[33],"efficiently,":[35],"yet":[36],"transiently,":[37],"deliver":[38,194],"Cas9":[39,79,111,131],"ribonucleoprotein":[42],"form":[43],"targeting":[44,137],"HIV":[46,139],"long":[47],"terminal":[48],"repeat":[49],"(LTR).":[50],"Gesicles":[51],"are":[52,188],"produced":[53],"through":[54],"expression":[55],"vesicular":[57],"stomatitis":[58],"virus":[59],"glycoprotein":[60],"package":[62],"protein":[63,132],"as":[64],"their":[65],"cargo,":[66],"thus":[67],"bypassing":[68],"need":[70],"for":[71],"transgene":[72],"delivery,":[73],"allowing":[75],"finer":[76],"control":[77],"expression.":[80],"Using":[81],"both":[82],"NanoSight":[83],"particle":[84],"western":[86,113],"blot":[87],"analysis,":[88],"we":[89,156],"verified":[90],"production":[91],"Cas9-containing":[93],"gesicles":[94,100,187],"by":[95,112,124],"HEK293FT":[96],"cells.":[97],"Application":[98],"CHME-5":[102,143],"microglia":[103],"resulted":[104,161],"rapid":[106],"but":[107,121],"transient":[108],"transfer":[109],"blot,":[114],"which":[115],"is":[116,122],"present":[117],"at":[118],"1":[119],"hr,":[120],"undetectable":[123],"24":[125],"hr":[126],"post-treatment.":[127],"Gesicle":[128],"delivery":[129],"preloaded":[133],"with":[134,172],"guide":[135],"RNA":[136],"LTR":[140,149],"HIV-NanoLuc":[142],"cells":[144],"generated":[145],"mutations":[146],"within":[147],"region":[150],"copy":[152],"number":[153],"loss.":[154],"Finally,":[155],"demonstrated":[157],"that":[158,186],"this":[159],"treatment":[160],"reduced":[163],"proviral":[164],"activity":[165],"under":[166],"basal":[167],"conditions":[168],"after":[170],"stimulation":[171],"pro-inflammatory":[173],"factors":[174],"lipopolysaccharide":[175],"(LPS)":[176],"or":[177],"tumor":[178],"necrosis":[179],"factor":[180],"alpha":[181],"(TNF-\u03b1).":[182],"These":[183],"data":[184],"suggest":[185],"viable":[190],"alternative":[191],"approach":[192],"technology.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":28},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":9}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-10-26T00:00:00"}